Brigitte Sola
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 18, 2023
The hen embryo: An alternative preclinical model in cancer
Journal: Medecine sciences : M/S
Published: October 11, 2022
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.
Journal: Cancers
Published: December 11, 2021
5,6-Epoxycholesterol Isomers Induce Oxiapoptophagy in Myeloma Cells.
Journal: Cancers
Published: June 21, 2021
Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death.
Journal: Cancers
Published: April 02, 2021
ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance.
Journal: Cells
Published: September 15, 2020
XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma.
Journal: Cancers
Published: September 11, 2020
Resistance to the Proteasome Inhibitors: Lessons from Multiple Myeloma and Mantle Cell Lymphoma.
Journal: Advances in experimental medicine and biology
Published: April 11, 2020
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells.
Journal: Oncogenesis
Published: April 03, 2020
Last Updated: 09/26/2026